Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mstone Partners Healthcare is a Hong Kong-based biotech and healthcare incubator organized as a holding company that founds, builds, and manages portfolio companies across life sciences, healthcare, aesthetics, and selected AI-related businesses. Established in 2016, the firm provides centralized support spanning IP licensing and management, clinical and regulatory strategy, R&D, investor relations, capital markets preparation, partnering, and M&A execution. Its life sciences focus appears concentrated in rare, pediatric, metabolic, neurodegenerative, respiratory, gastrointestinal, liver, lipid, dermatology, and aesthetics-related opportunities. Rather than operating as a single-asset drug developer, Mstone functions as a hub-and-spoke company builder with multiple portfolio companies and pipeline assets under development. The company also highlights commercial activity in aesthetics products and global market presence through affiliated businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mstone Partners Healthcare.